{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:13:35Z","timestamp":1790993615022,"version":"4.1.0"},"reference-count":3,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2026.1775222","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:52:27Z","timestamp":1769014347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Editorial: Vitiligo: from obscurity to spotlight \u2013 Advancing care with new therapies and AI"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Valle","sequence":"first","affiliation":[{"name":"Vitiligo Research Foundation","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torello","family":"Lotti","sequence":"additional","affiliation":[{"name":"Prisca Sapientia Institut, University Zurich","place":["Zurich, Switzerland"]},{"name":"Istituto Superiore di Medicina","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.36849\/JDD.9011","article-title":"National institutes of health funding for vitiligo research: trends from 1985 to 2024","volume":"24","author":"Hamid","year":"2025","journal-title":"J Drugs Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/dth.12121","article-title":"Acridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study","volume":"27","author":"Korobko","year":"2014","journal-title":"Dermatol Ther"},{"key":"B3","unstructured":"Vitiligo Research Foundation; c2011-2025."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1775222\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:52:28Z","timestamp":1769014348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1775222\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":3,"alternative-id":["10.3389\/fmed.2026.1775222"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1775222","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1775222"}}